Cargando…

AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway

The natural tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) is generated from the N-terminus of thymosin-β4 through enzymatic cleavage by prolyl oligopeptidase (POP). AcSDKP regulation of proliferation of different cells is implicated in hematopoiesis and angiogenesis. This tetrapeptide present in al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ping, Li, Bin, Zhang, Wenhua, Li, Yijian, Li, Guang, Jiang, Xinnong, Wdzieczak-Bakala, Joanna, Liu, Jianmiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820705/ https://www.ncbi.nlm.nih.gov/pubmed/24244481 http://dx.doi.org/10.1371/journal.pone.0079321

Ejemplares similares

Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
por: Boutonnat, Jean, et al.
Publicado: (2005)

AcSDKP is down-regulated in anaemia induced by Trypanosoma brucei infection in mice
por: Musaya, Janelisa, et al.
Publicado: (2017)

A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP
por: Danilov, Sergei M., et al.
Publicado: (2014)

Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction
por: Nakagawa, Pablo, et al.
Publicado: (2018)

Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
por: Masuyer, Geoffrey, et al.
Publicado: (2015)

The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis
por: Wang, Wei, et al.
Publicado: (2022)

Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment
por: Mao, Na, et al.
Publicado: (2021)

Influence of the interaction between Ac-SDKP and Ang II on the pathogenesis and development of silicotic fibrosis
por: Zhang, Yi, et al.
Publicado: (2018)

A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis
por: Xu, Hong, et al.
Publicado: (2012)

Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
por: Zuo, Yiqin, et al.
Publicado: (2013)

Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica by Inhibition of TLR4 and RANKL Signaling Pathways
por: Jin, Fuyu, et al.
Publicado: (2021)

Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
por: Conte, Enrico, et al.
Publicado: (2016)

Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow
por: Sharma, Umesh C., et al.
Publicado: (2018)

PI3KCA Mutations in Uterine Cervix Carcinoma
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Knockdown of AKT3 (PKB γ) and PI3KCA Suppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells
por: Paul-Samojedny, Monika, et al.
Publicado: (2014)

The PI3KCA and AKT Inhibitory Activities of Litsea Cubeba Lour. Fruits and Heartwoods Towards Hela Cells
por: Dalimunthe, Aminah, et al.
Publicado: (2019)

Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice
por: Han, Suo, et al.
Publicado: (2023)

Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica
por: Xiaojun, Wang, et al.
Publicado: (2016)

Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report
por: Hinich, Maayan Geller, et al.
Publicado: (2023)

The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis
por: Mnguni, Ayanda Trevor, et al.
Publicado: (2015)

KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways
por: Huang, Chunling, et al.
Publicado: (2016)

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway
por: Lin, Hai, et al.
Publicado: (2015)

Effects of KCa channels on biological behavior of trophoblasts
por: Zhang, Xiaolei, et al.
Publicado: (2022)

Low Voltage Activation of KCa1.1 Current by Cav3-KCa1.1 Complexes
por: Rehak, Renata, et al.
Publicado: (2013)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction
por: Firoozi, Saman, et al.
Publicado: (2020)

Activation of PKG and Akt Is Required for Cardioprotection by Ramelteon-Induced Preconditioning and Is Located Upstream of mKCa-Channels
por: Torregroza, Carolin, et al.
Publicado: (2020)

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere
por: Li, Jing, et al.
Publicado: (2013)

Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway
por: Hao, Jiaqi, et al.
Publicado: (2017)

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
por: Derbel, Olfa, et al.
Publicado: (2013)

Laminar shear stress alters endothelial KCa2.3 expression in H9c2 cells partially via regulating the PI3K/Akt/p300 axis
por: Li, Guojian, et al.
Publicado: (2019)

Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2
por: Zhang, Ke, et al.
Publicado: (2023)

MoKCa database—mutations of kinases in cancer
por: Richardson, Christopher J., et al.
Publicado: (2009)

Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population
por: Wang, Yang, et al.
Publicado: (2018)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection
por: Ruiz, Aldrick, et al.
Publicado: (2019)

Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer
por: Bredemeier, Maren, et al.
Publicado: (2017)

The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells
por: Liu, Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_09hqser6e7ie82a6p4ibapidq8